CDEK
← All organizations

Highest phase reached

Phase 3

First clinical trial

Jul 1, 2005

Last known activity

Jul 1, 2012

Acquired by CSL Behring on Jan 1, 2004

Timeline

1910s

  1. Jan 1, 1916

    CSL— Founded

2000s

  1. Jan 1, 2004

    CSL Behring— Acquired By

  2. Jan 1, 2004

    Centeon— Acquired

Drugs by trial phase (6 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 3 total across the full acquisition tree)

Recent trials (11)

Details

Founded
AU Jan 1, 1916
Last known activity
Jul 1, 2012

Notes

"2004: CSL completes the acquisition of Aventis Behring, combining it with ZLB Bioplasma to create ZLB Behring, today known as CSL Behring." https://www.cslbehring.cz/company-history